Skip to main content

Advertisement

Log in

Impact of gender on bladder cancer incidence, staging, and prognosis

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction

While patient gender is an important factor in the clinical decision-making for the management of bladder cancer, there are minimal evidence-based recommendations to guide health care professionals. Recent epidemiologic and translational research has shed some light on the complex relationship between gender and bladder cancer. Our aim was to review the literature on the effect of gender on bladder cancer incidence, biology, mortality, and treatment.

Methods

Using MEDLINE, we performed a search of the literature between January 1975 and April 2011.

Results

Although men are nearly 3–4 times more likely to develop bladder cancer than women, women present with more advanced disease and have worse survival. Recently, a number of population-based and multicenter collaborative studies have shown that female gender is associated with a significantly higher rate of cancer-specific recurrence and mortality after radical cystectomy. The disparity between genders is proposed to be the result of a differences exposure to carcinogens (i.e., tobacco and chemicals) as well as reflective of genetic, anatomic, hormonal, societal, and environmental factors. Explanations for the differential behavior of bladder cancer between genders include sex steroids and their receptors as well as inferior quality of care for women (inpatient length of stay, referral patterns, and surgical outcomes).

Conclusions

It is imperative that health care practitioners and researchers from disparate disciplines collectively focus efforts to appropriately develop gender-specific evidence-based guidelines for bladder cancer patients. We must strive to develop multidisciplinary collaborative efforts to provide tailored gender-specific care for bladder cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  2. Sievert KD, Amend B, Nagele U et al (2009) Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27:295–300

    Article  PubMed  CAS  Google Scholar 

  3. Herman MP, Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF (2008) Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva Urol Nefrol 60:217–235

    PubMed  CAS  Google Scholar 

  4. Shariat SF, Karakiewicz PI, Palapattu GS, et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414–22 (discussion 22)

    Google Scholar 

  5. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19:666–675

    PubMed  CAS  Google Scholar 

  6. Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696

    Article  PubMed  Google Scholar 

  7. USIo Medicine (2001) Exploring the biological contributions to human health: does sex matter? J Womens Health Gend Based Med 10:433–439

    Article  Google Scholar 

  8. Pushkar DY, Govorov AV, Matveev VB (2008) The epidemiology of bladder cancer in Russia. Scand J Urol Nephrol Suppl 218:21–24

    Google Scholar 

  9. Puente D, Malats N, Cecchini L et al (2003) Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 43:53–62

    Article  PubMed  CAS  Google Scholar 

  10. Horstmann M, Witthuhn R, Falk M, Stenzl A (2008) Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med 5:385–394

    Article  PubMed  Google Scholar 

  11. Mungan NA, Aben KK, Schoenberg MP et al (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55:876–880

    Article  PubMed  CAS  Google Scholar 

  12. Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA (2000) Gender differences in stage distribution of bladder cancer. Urology 55:368–371

    Article  PubMed  CAS  Google Scholar 

  13. Pou SA, Osella AR, Diaz MeP (2011) Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986–2006). Cancer Causes Control 22:407–415

    Article  PubMed  Google Scholar 

  14. Tracey E, Roder D, Luke C, Bishop J (2009) Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men? BJU Int 104:498–504

    Article  PubMed  Google Scholar 

  15. Svatek RS, Shariat SF, Dinney C et al (2009) Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study (abstract #1744). J Urol 181:629

    Article  Google Scholar 

  16. Jeldres C, Isbarn H, Capitanio U et al (2009) Gender is an important predictor of cancer-specific survival in patients with urothelial carcinoma after radical cystectomy (abstract #1761). J Urol 181:635

    Article  Google Scholar 

  17. Datta GD, Neville B, Datta NS, Earle C (2006) Gender disparities in bladder cancer survival: An assessment of socio-demographic factors. AACR Meeting Abstracts. 2006:B38 (2006 November 1)

  18. Scosyrev E, Noyes K, Feng C, Messing E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115:68–74

    Article  PubMed  Google Scholar 

  19. Tilki D, Reich O, Svatek RS et al (2010) Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol 183:1757–1763

    Article  PubMed  Google Scholar 

  20. Tilki D, Svatek RS, Novara G et al (2010) Stage pT0 at radical cystectomy confers improved survival: an international study of 4, 430 patients. J Urol 184:888–894

    Article  PubMed  Google Scholar 

  21. Tilki D, Svatek RS, Karakiewicz PI et al (2010) Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183:87–93

    Article  PubMed  Google Scholar 

  22. Liberman D, Alasker A, Sun M et al (2011) Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int 107:905–911

    Article  PubMed  Google Scholar 

  23. Yafi FA, Duclos M, Correa JA, Tanguay S, Aprikian AG, Cury F, Souhami L, Rajan R, Kassouf W (2011) Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer. Urol Oncol 29(3):309–313

    Google Scholar 

  24. Brookfield KF, Cheung MC, Gomez C et al (2009) Survival disparities among African American women with invasive bladder cancer in Florida. Cancer 115:4196–4209

    Article  PubMed  Google Scholar 

  25. Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 121:e46–e215

    Article  PubMed  Google Scholar 

  26. Hemelt M, Yamamoto H, Cheng KK, Zeegers MP (2009) The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 124:412–419

    Article  PubMed  CAS  Google Scholar 

  27. Hartge P, Harvey EB, Linehan WM et al (1990) Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82:1636–1640

    Article  PubMed  CAS  Google Scholar 

  28. McGrath M, Michaud DS, De Vivo I (2006) Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163:236–244

    Article  PubMed  Google Scholar 

  29. Okajima E, Hiramatsu T, Iriya K, Ijuin M, Matsushima S (1975) Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res 3:73–79

    Article  PubMed  CAS  Google Scholar 

  30. Miyamoto H, Yang Z, Chen YT et al (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99:558–568

    Article  PubMed  CAS  Google Scholar 

  31. Boorman GA (1977) Animal model of human disease: carcinoma of the ureter and urinary bladder. Am J Pathol 88:251–254

    PubMed  CAS  Google Scholar 

  32. Imada S, Akaza H, Ami Y, Koiso K, Ideyama Y, Takenaka T (1997) Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. Eur Urol 31:360–364

    PubMed  CAS  Google Scholar 

  33. Zhuang YH, Blauer M, Tammela T, Tuohimaa P (1997) Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology 30:556–562

    Article  PubMed  CAS  Google Scholar 

  34. Boorjian S, Ugras S, Mongan NP et al (2004) Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64:383–388

    Article  PubMed  Google Scholar 

  35. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH (1991) Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 39:927–936

    Article  PubMed  CAS  Google Scholar 

  36. Chen F, Langenstroer P, Zhang G, Iwamoto Y, See WA (2003) Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. J Urol 170:2009–2013

    Article  PubMed  CAS  Google Scholar 

  37. Boorjian S, Ugras S, Mongan NP et al (2004) Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64:383–388

    Article  PubMed  Google Scholar 

  38. Tuygun C, Kankaya D, Imamoglu A et al (2011) Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 29:43–51

    Article  PubMed  CAS  Google Scholar 

  39. Mir C, Shariat SF, Van Der Kwast TH et al (2010) Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int. doi:10.1111/j.1464-410X.2010.09834.x

  40. Shen SS, Smith CL, Hsieh JT et al (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106:2610–2616

    Article  PubMed  CAS  Google Scholar 

  41. Bolenz C, Lotan Y, Ashfaq R, Shariat SF (2009) Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol 56:1093–1095

    Article  PubMed  Google Scholar 

  42. Sonpavde G, Okuno N, Weiss H et al (2007) Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology 69:1221–1226

    Article  PubMed  Google Scholar 

  43. Pelletier G (2000) Localization of androgen and estrogen receptors in rat and primate tissues. Histol Histopathol 15:1261–1270

    PubMed  CAS  Google Scholar 

  44. Makela S, Strauss L, Kuiper G et al (2000) Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. Mol Cell Endocrinol 170:219–229

    Article  PubMed  CAS  Google Scholar 

  45. Saez S, Martin PM (1981) Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem 15:317–320

    Article  PubMed  CAS  Google Scholar 

  46. Shen SS, Smith CL, Hsieh JT et al (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106:2610–2616

    Article  PubMed  CAS  Google Scholar 

  47. Wolpert BJ, Amr S, Saleh DA et al (2011) Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt. Urol Oncol [Epub ahead of print]

  48. Taub DA, Hollenbeck BK, Cooper KL et al (2006) Racial disparities in resource utilization for cystectomy. Urology 67:288–293

    Article  PubMed  Google Scholar 

  49. Cárdenas-Turanzas M, Cooksley C, Kamat AM, Pettaway CA, Elting LS (2008) Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. Int Urol Nephrol 40:893–899

    Article  PubMed  Google Scholar 

  50. Siegrist T, Savage C, Shabsigh A, Cronin A, Donat SM (2010) Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urol Oncol 28:112–117

    Article  PubMed  Google Scholar 

  51. Liberman D, Lughezzani G, Sun M et al (2011) Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 77:660–666

    Article  PubMed  Google Scholar 

  52. Nagele U, Anastasiadis AG, Stenzl A, Kuczyk M (2011) Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results. World J Urol [Epub ahead of print]

  53. Porter MP, Gore JL, Wright JL (2011) Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study. World J Urol 29:73–77

    Article  PubMed  Google Scholar 

  54. Schulman KA, Berlin JA, Harless W et al (1999) The effect of race and sex on physicians’ recommendations for cardiac catheterization. N Engl J Med 340:618–626

    Article  PubMed  CAS  Google Scholar 

  55. Johnson EK, Daignault S, Zhang Y, Lee CT (2008) Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 72:498–502 discussion -3

    Article  PubMed  Google Scholar 

  56. Nielsen ME, Palapattu GS, Karakiewicz PI et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100:1015–1020

    PubMed  Google Scholar 

  57. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009) Project UDiA. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115:988–996

    Article  PubMed  Google Scholar 

  58. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM (2011) Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol 185:1631–1636

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harun Fajkovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fajkovic, H., Halpern, J.A., Cha, E.K. et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29, 457–463 (2011). https://doi.org/10.1007/s00345-011-0709-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-011-0709-9

Keywords

Navigation